Showing results (61-70 of 993) with videos related to

Sort By:
Pageof 100
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang, Eldad Melamed, Werner Poewe, et al.
The Lancet Regional Health. Europe|January 19, 2026
Management of Parkinson's disease psychosis-a European perspectiveWalter Pirker, Joaquim J Ferreira, Olivier Rascol, et al.
Experimental Neurology|May 25, 2010
Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failureSylvia Stemberger, Werner Poewe, Gregor K Wenning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2005
In vitro models of multiple system atrophyNadia Stefanova, Markus Reindl, Werner Poewe, et al.
Neurodegenerative Disease Management|December 15, 2018
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA RegistryWerner Poewe, K Ray Chaudhuri, Lars Bergmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2021
On-Demand Therapy for OFF Episodes in Parkinson's DiseaseC Warren Olanow, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2005
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004Christopher G Goetz, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2005
How to diagnose dementia with Lewy bodies: state of the artFelix Geser, Gregor K Wenning, Werner Poewe, et al.
The Lancet. Neurology|January 30, 2004
Multiple system atrophyGregor K Wenning, Carlo Colosimo, Felix Geser, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 5, 2012
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFERPeter A LeWitt, Babak Boroojerdi, Erwin Surmann, et al.
Pageof 100